Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SCYX

+ Watchlist+ Portfolio

SCYNEXIS, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.85
52-Week Range
$2.70 – $9.12
Market Cap
$28.07M
P/E (TTM)
—
EPS (TTM)
-0.23
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.48
PEG Ratio
—
Return on Equity
-21.16%
Return on Assets
-25.16%
Gross Margin
100.00%
Operating Margin
-126.86%
Profit Margin
-53.50%
Current Ratio
7.57
Debt/Equity
0.03
Total Debt
$1.82M
Free Cash Flow
$-6.90M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-17.28M

Market Snapshot

About

SCYNEXIS, Inc. is a biotechnology company focused on developing novel anti-infectives to address unmet medical needs. The company lead product candidate targets invasive fungal infections in immunocompromised patients who have limited or no treatment options.